Loxoprofen Sodium Market In Global
Loxoprofen sodium (CAS 80382-23-6) is a nonselective inhibitor of COX-1 and COX-2 that exhibits p ... Read More
Sotrastaurin is a protein kinase C inhibitor for the prevention of transplant rejection and treatment of psoriasis.
This report contains market size and forecasts of Sotrastaurin(PKC Inhibitor) in global, including the following market information:
Global Sotrastaurin(PKC Inhibitor) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sotrastaurin(PKC Inhibitor) Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Sotrastaurin(PKC Inhibitor) companies in 2021 (%)
The global Sotrastaurin(PKC Inhibitor) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sotrastaurin(PKC Inhibitor) include Abcam, BioVision, Adooq Bioscience, Selleck Chemicals, TargetMol, BOC Sciences, Santa Cruz Biotechnology, Cayman Chemical and Toronto Research Chemicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sotrastaurin(PKC Inhibitor) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sotrastaurin(PKC Inhibitor) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Sotrastaurin(PKC Inhibitor) Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Sotrastaurin(PKC Inhibitor) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Sotrastaurin(PKC Inhibitor) Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Sotrastaurin(PKC Inhibitor) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Sotrastaurin(PKC Inhibitor) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sotrastaurin(PKC Inhibitor) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sotrastaurin(PKC Inhibitor) revenues share in global market, 2021 (%)
Key companies Sotrastaurin(PKC Inhibitor) sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Sotrastaurin(PKC Inhibitor) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abcam
BioVision
Adooq Bioscience
Selleck Chemicals
TargetMol
BOC Sciences
Santa Cruz Biotechnology
Cayman Chemical
Toronto Research Chemicals
AbMole
APExBIO Technology
Axon Medchem
Key Organics
Taiclone
Biorbyt
Aladdin
Loxoprofen sodium (CAS 80382-23-6) is a nonselective inhibitor of COX-1 and COX-2 that exhibits p ... Read More
Solasodine is a potentially useful precursor for steroidal compounds and hormones, this is usual ... Read More
Oclacitinib is a novel Janus kinase inhibitor with activity against cytokines involved in allergy ... Read More
Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, ... Read More